Elaidi, R.; Phan, L.; Borchiellini, D.; Barthelemy, P.; Ravaud, A.; Oudard, S.; Vano, Y.
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. Cancers 2020, 12, 1673.
https://doi.org/10.3390/cancers12061673
AMA Style
Elaidi R, Phan L, Borchiellini D, Barthelemy P, Ravaud A, Oudard S, Vano Y.
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. Cancers. 2020; 12(6):1673.
https://doi.org/10.3390/cancers12061673
Chicago/Turabian Style
Elaidi, Reza, Letuan Phan, Delphine Borchiellini, Philippe Barthelemy, Alain Ravaud, Stéphane Oudard, and Yann Vano.
2020. "Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis" Cancers 12, no. 6: 1673.
https://doi.org/10.3390/cancers12061673
APA Style
Elaidi, R., Phan, L., Borchiellini, D., Barthelemy, P., Ravaud, A., Oudard, S., & Vano, Y.
(2020). Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. Cancers, 12(6), 1673.
https://doi.org/10.3390/cancers12061673